In 2010 the CLS performed an imaging experiment to create a 3-D tomographic image of the head of a mouse (below). Additional experiments have studied an array of soft tissue samples for medical research, ranging from characterizing eardrum structure to tumor detection.
The Lyncean CLS has screened and collected data sets on several proteins at X-ray energies ranging from 12 keV to 18 keV. Details of the CLS’s first diffraction dataset on a novel protein are in the published paper with the ATCG3D collaboration. The protein structure was solved and published to the RCSB Protein Data Bank (3IFT).
The requirements for differential phase contrast imaging (DPCI) are extremely well matched to the characteristics of the X-ray beam from the CLS because DPCI can use the full bandwidth (few percent), native CLS beam without any X-ray optics.
The latest development program at Lyncean Technologies is the Compact EUV Source (CES), an accelerator based 1 kW EUV lithography source. Much of the technology that will be developed for the CES is leveraged from the technology from the CLS. In addition, accelerator based sources generate light in a clean, high vacuum environment and are inherently very reliable, two features that make them ideal for high volume manufacturing.